← Back to headlines
Ariel Global Fund Re-Adds Bristol-Myers Squibb (BMY) Citing Pipeline Strength and Valuation
The Ariel Global Fund has re-added Bristol-Myers Squibb Company (BMY) to its portfolio, citing the company's strong pipeline and attractive valuation as key factors.
31 Mar, 12:04 — 31 Mar, 12:04
Sources
Showing 1 of 1 sources
Related Stories
The OLB Group Reports Q2 Financials; FinVolution Group to Announce Results
1h ago
Mark Cuban and Tech Founders Oppose California Wealth Tax Proposal
5h ago
Greece to Save €2 Billion by Early Debt Repayment in 2026
5h ago
SEC Proposal Would Allow Companies to Announce Earnings Quarterly, Ditch Filings
6h ago